The Environmental Protection Agency's budget would be cut by 54% under President Trump's initial FY 2026 budget request from ...

Universities and companies that turn discoveries into medicines in Seattle have searched for “safe harbor” from the White ...

A team led by Rice University bioscientist Caroline Ajo-Franklin has discovered how certain bacteria breathe by generating ...

Cancer research in the U.S. doesn’t rely on a single institution or funding stream − it’s a complex ecosystem made up of interdependent parts: academia, pharmaceutical companies, biotechnology ...

China is publishing more research, is applying for more patents, has more researchers and is accelerating efforts that fuel scientific discoveries, while the U.S. has plateaued or is decreasing ...

UK investment firm Aviva Capital Partners is supporting a major new life sciences expansion in south London, which aims to ...

We unpack the full scope of the U.S. budget cuts, from canceled clinical trials and stalled drug approvals to mass layoffs ...

More than a hundred experts in molecular simulation have published a paper in the journal Nature Methods calling for a paradigm shift in molecular dynamics data management.

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.

Commissioners visit UD-based NIIMBL, where public-private partnerships promote innovation, workforce development ...